Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Panel Back On Track For TransMedics’ Heart Device After Missing A Few Beats

Executive Summary

The US FDA will host an advisory committee webcast to discuss approval of the company’s new heart transplant device a year after it was originally planned.

You may also be interested in...



TransMedics Faces 2nd Panel Date Postponement

The company said the postponement will give the US FDA additional time to review trial data.

FDA May Webcast First MDUFA Meeting, Postpone Or Cancel Others

The FDA says it is looking to webcast the upcoming 7 April MDUFA user fee public meeting, which is slated to be one of the most important agency meetings of the year. The decision comes in light of difficulties holding in-person meetings as the US grapples with the ongoing coronavirus crisis.

Massive Family Dollar Rat Infestation Leads To Multi-State Recall

The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143582

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel